Company Amorphis Pharma Development
Amorphis Pharma Development
KRSCompany age:
Age:
6 y. 11 m. 25 d.
Share capital:
Share capital:
5 000 PLN
Company suspended its operations from 2024-01-01
Information about a legal entity:
| KRS | 0000760620 |
| REGON | 38192563600000 |
| NIP |
9542799406
from 2019-01-04 to 2024-07-24 Niezarejestrowany |
| Official name | AMORPHIS PHARMA DEVELOPMENT |
| Registration address | UL. BANKOWA 12-147, PL-40-007, KATOWICE |
| KRS registered | 2018-11-30 |
| Legal form | Spółka z ograniczoną odpowiedzialnością |
| Main industry industry classification (Polska Klasyfikacja Działalności) |
Manufacture of basic pharmaceutical products |
History of legal entity data changes:
|
2024-06-28 | |||
|
2024-06-28 | |||
|
2024-06-28 | |||
|
2024-03-01 | |||
|
2023-10-30 | |||
|
2023-06-21 | |||
|
2023-06-21 | |||
|
2023-06-21 | |||
|
2022-09-29 | |||
|
2022-09-29 | |||
|
2022-09-29 | |||
|
2021-06-30 | |||
|
2021-06-30 | |||
|
2021-06-30 | |||
|
2020-06-23 | |||
|
2020-06-23 | |||
|
2020-06-23 | |||
|
2020-06-05 | |||
|
2020-05-04 | |||
|
2019-05-30 | |||
|
2018-11-30 | |||
|
2018-11-30 | |||
|
2018-11-30 |
Information source: National Court Register.